The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
The global Tasigna market was valued at US$ 1923 million in 2023 and is anticipated to reach US$ 1200.7 million by 2030, witnessing a CAGR of -5.4% during the forecast period 2024-2030.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
This report aims to provide a comprehensive presentation of the global market for Tasigna, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tasigna.
Report Scope
The Tasigna market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tasigna market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tasigna manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
50mg
200mg
Other
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tasigna manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tasigna in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
The global Tasigna market was valued at US$ 1923 million in 2023 and is anticipated to reach US$ 1200.7 million by 2030, witnessing a CAGR of -5.4% during the forecast period 2024-2030.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
This report aims to provide a comprehensive presentation of the global market for Tasigna, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tasigna.
Report Scope
The Tasigna market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tasigna market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tasigna manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
50mg
200mg
Other
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tasigna manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tasigna in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tasigna Market Overview
1.1 Product Overview and Scope of Tasigna
1.2 Tasigna Segment by Type
1.2.1 Global Tasigna Market Value Comparison by Type (2024-2030)
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Tasigna Segment by Application
1.3.1 Global Tasigna Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Tasigna Market Size Estimates and Forecasts
1.4.1 Global Tasigna Revenue 2019-2030
1.4.2 Global Tasigna Sales 2019-2030
1.4.3 Global Tasigna Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tasigna Market Competition by Manufacturers
2.1 Global Tasigna Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tasigna Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tasigna Average Price by Manufacturers (2019-2024)
2.4 Global Tasigna Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tasigna, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tasigna, Product Type & Application
2.7 Tasigna Market Competitive Situation and Trends
2.7.1 Tasigna Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tasigna Players Market Share by Revenue
2.7.3 Global Tasigna Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tasigna Retrospective Market Scenario by Region
3.1 Global Tasigna Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tasigna Global Tasigna Sales by Region: 2019-2030
3.2.1 Global Tasigna Sales by Region: 2019-2024
3.2.2 Global Tasigna Sales by Region: 2025-2030
3.3 Global Tasigna Global Tasigna Revenue by Region: 2019-2030
3.3.1 Global Tasigna Revenue by Region: 2019-2024
3.3.2 Global Tasigna Revenue by Region: 2025-2030
3.4 North America Tasigna Market Facts & Figures by Country
3.4.1 North America Tasigna Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tasigna Sales by Country (2019-2030)
3.4.3 North America Tasigna Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Tasigna Market Facts & Figures by Country
3.5.1 Europe Tasigna Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tasigna Sales by Country (2019-2030)
3.5.3 Europe Tasigna Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tasigna Market Facts & Figures by Country
3.6.1 Asia Pacific Tasigna Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tasigna Sales by Country (2019-2030)
3.6.3 Asia Pacific Tasigna Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tasigna Market Facts & Figures by Country
3.7.1 Latin America Tasigna Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tasigna Sales by Country (2019-2030)
3.7.3 Latin America Tasigna Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tasigna Market Facts & Figures by Country
3.8.1 Middle East and Africa Tasigna Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tasigna Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tasigna Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tasigna Sales by Type (2019-2030)
4.1.1 Global Tasigna Sales by Type (2019-2024)
4.1.2 Global Tasigna Sales by Type (2025-2030)
4.1.3 Global Tasigna Sales Market Share by Type (2019-2030)
4.2 Global Tasigna Revenue by Type (2019-2030)
4.2.1 Global Tasigna Revenue by Type (2019-2024)
4.2.2 Global Tasigna Revenue by Type (2025-2030)
4.2.3 Global Tasigna Revenue Market Share by Type (2019-2030)
4.3 Global Tasigna Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tasigna Sales by Application (2019-2030)
5.1.1 Global Tasigna Sales by Application (2019-2024)
5.1.2 Global Tasigna Sales by Application (2025-2030)
5.1.3 Global Tasigna Sales Market Share by Application (2019-2030)
5.2 Global Tasigna Revenue by Application (2019-2030)
5.2.1 Global Tasigna Revenue by Application (2019-2024)
5.2.2 Global Tasigna Revenue by Application (2025-2030)
5.2.3 Global Tasigna Revenue Market Share by Application (2019-2030)
5.3 Global Tasigna Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Tasigna Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Tasigna Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tasigna Industry Chain Analysis
7.2 Tasigna Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tasigna Production Mode & Process
7.4 Tasigna Sales and Marketing
7.4.1 Tasigna Sales Channels
7.4.2 Tasigna Distributors
7.5 Tasigna Customers
8 Tasigna Market Dynamics
8.1 Tasigna Industry Trends
8.2 Tasigna Market Drivers
8.3 Tasigna Market Challenges
8.4 Tasigna Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
